These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
598 related articles for article (PubMed ID: 28216578)
1. Tumor Microenvironment, a Paradigm in Hepatocellular Carcinoma Progression and Therapy. Tahmasebi Birgani M; Carloni V Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28216578 [TBL] [Abstract][Full Text] [Related]
2. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever. Carloni V; Luong TV; Rombouts K Liver Int; 2014 Jul; 34(6):834-43. PubMed ID: 24397349 [TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo. Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic modulators of hepatic stellate cells for hepatocellular carcinoma. Ruan Q; Wang H; Burke LJ; Bridle KR; Li X; Zhao CX; Crawford DHG; Roberts MS; Liang X Int J Cancer; 2020 Sep; 147(6):1519-1527. PubMed ID: 32010970 [TBL] [Abstract][Full Text] [Related]
5. Components of the Hepatocellular Carcinoma Microenvironment and Their Role in Tumor Progression. Novikova MV; Khromova NV; Kopnin PB Biochemistry (Mosc); 2017 Aug; 82(8):861-873. PubMed ID: 28941454 [TBL] [Abstract][Full Text] [Related]
6. Emerging role of adipokine apelin in hepatic remodelling and initiation of carcinogensis in chronic hepatitis C patients. Farid RM; Abu-Zeid RM; El-Tawil A Int J Clin Exp Pathol; 2014; 7(5):2707-17. PubMed ID: 24966992 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of hepatocellular carcinoma contributes to cancer progression. Jeng KS; Chang CF; Jeng WJ; Sheen IS; Jeng CJ Crit Rev Oncol Hematol; 2015 Jun; 94(3):337-47. PubMed ID: 25680939 [TBL] [Abstract][Full Text] [Related]
8. Cancer-associated fibroblasts in hepatocellular carcinoma. Kubo N; Araki K; Kuwano H; Shirabe K World J Gastroenterol; 2016 Aug; 22(30):6841-50. PubMed ID: 27570421 [TBL] [Abstract][Full Text] [Related]
9. The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma. Baglieri J; Brenner DA; Kisseleva T Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959975 [TBL] [Abstract][Full Text] [Related]
10. ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma. Xie YX; Liao R; Pan L; Du CY Immunol Lett; 2017 Aug; 188():116-123. PubMed ID: 28668554 [TBL] [Abstract][Full Text] [Related]
11. Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma. Rani B; Cao Y; Malfettone A; Tomuleasa C; Fabregat I; Giannelli G World J Gastroenterol; 2014 Apr; 20(15):4128-40. PubMed ID: 24764651 [TBL] [Abstract][Full Text] [Related]
13. Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma. Sircana A; Paschetta E; Saba F; Molinaro F; Musso G Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30970564 [TBL] [Abstract][Full Text] [Related]
14. A novel spontaneous hepatocellular carcinoma mouse model for studying T-cell exhaustion in the tumor microenvironment. Liu YT; Tseng TC; Soong RS; Peng CY; Cheng YH; Huang SF; Chuang TH; Kao JH; Huang LR J Immunother Cancer; 2018 Dec; 6(1):144. PubMed ID: 30526672 [TBL] [Abstract][Full Text] [Related]
15. A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection. Zhang DY; Goossens N; Guo J; Tsai MC; Chou HI; Altunkaynak C; Sangiovanni A; Iavarone M; Colombo M; Kobayashi M; Kumada H; Villanueva A; Llovet JM; Hoshida Y; Friedman SL Gut; 2016 Oct; 65(10):1754-64. PubMed ID: 26045137 [TBL] [Abstract][Full Text] [Related]
16. A novel three-dimensional culture system maintaining the physiological extracellular matrix of fibrotic model livers accelerates progression of hepatocellular carcinoma cells. Miyauchi Y; Yasuchika K; Fukumitsu K; Ishii T; Ogiso S; Minami T; Kojima H; Yamaoka R; Katayama H; Kawai T; Yoshitoshi-Uebayashi EY; Kita S; Yasuda K; Sasaki N; Uemoto S Sci Rep; 2017 Aug; 7(1):9827. PubMed ID: 28851916 [TBL] [Abstract][Full Text] [Related]
17. Molecular Mechanisms and Targets of Therapy for Hepatocellular Carcinoma. Klungboonkrong V; Das D; McLennan G J Vasc Interv Radiol; 2017 Jul; 28(7):949-955. PubMed ID: 28416267 [TBL] [Abstract][Full Text] [Related]
18. Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities. Lu C; Rong D; Zhang B; Zheng W; Wang X; Chen Z; Tang W Mol Cancer; 2019 Aug; 18(1):130. PubMed ID: 31464625 [TBL] [Abstract][Full Text] [Related]
19. Tumor microenviroment and hepatocellular carcinoma metastasis. Wang H; Chen L J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():43-8. PubMed ID: 23855295 [TBL] [Abstract][Full Text] [Related]